HK Stock MarketDetailed Quotes

01880 CTG DUTY-FREE

Watchlist
  • 56.100
  • +0.250+0.45%
Market Closed Jul 19 16:08 CST
116.06BMarket Cap17.05P/E (TTM)

CTG DUTY-FREE Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Turnover
----
-9.45%18.81B
24.08%67.54B
29.14%50.84B
----
23.76%20.77B
-19.57%54.43B
-20.47%39.36B
--27.65B
-7.45%16.78B
Operating income
-12.81%31.26B
-9.45%18.81B
24.08%67.54B
29.14%50.84B
29.68%35.86B
23.76%20.77B
-19.57%54.43B
-20.47%39.36B
27.65B
-7.45%16.78B
Cost of sales
----
----
-17.98%-46.69B
----
----
----
12.80%-39.57B
----
---18.43B
----
Operating expenses
14.94%-12.54B
-17.98%-46.69B
-28.15%-34.7B
-33.14%-14.75B
12.80%-39.57B
14.08%-27.08B
-18.43B
-0.87%-11.08B
Gross profit
4.00%6.26B
40.33%20.85B
31.33%16.14B
5.56%6.02B
-33.34%14.86B
-31.68%12.29B
9.22B
-20.22%5.71B
Selling expenses
----
-17.90%-2.41B
-117.13%-10.74B
-162.28%-6.94B
----
-40.14%-2.05B
8.52%-4.95B
-28.36%-2.65B
---2.46B
34.55%-1.46B
Administrative expenses
----
-6.54%-475.64M
-1.10%-2.6B
-15.74%-1.54B
----
-3.58%-446.46M
5.16%-2.57B
-4.08%-1.33B
---1.07B
18.88%-431.04M
Research and development expenses
----
49.22%-355K
-49.69%-58.42M
---9.78M
----
---699.06K
---39.03M
----
----
----
Profit from asset sales
----
-673.05%-1.52M
----
-53.02%1.09M
----
-123.95%-196.59K
----
286.02%2.31M
----
--820.78K
Impairment and provision
----
-5.16%-147.19M
-64.00%2.58M
-44.35%-473.95M
----
-407.71%-139.97M
130.70%7.16M
-110.31%-328.34M
--7.58M
1,811.40%45.49M
-Other impairment is provision
----
-5.16%-147.19M
-64.00%2.58M
-44.35%-473.95M
----
-407.71%-139.97M
130.70%7.16M
-110.31%-328.34M
--7.58M
1,811.40%45.49M
Special items of operating profit
----
29.38%22.76M
255.24%1.49B
-72.08%68.58M
----
-65.32%17.59M
-46.58%420.08M
-25.37%245.63M
---334.17M
-64.76%50.73M
Operating profit
-8.47%4.53B
-2.12%2.78B
15.75%8.95B
-17.91%5.99B
-7.59%4.95B
-16.92%2.84B
-48.25%7.73B
-45.90%7.3B
5.36B
-24.44%3.42B
Financing cost
----
-59.74%124.94M
-53.41%-297.89M
193.04%581.83M
----
289.80%310.32M
12.48%-194.18M
-991.32%-625.37M
---111.07M
251.89%79.61M
Share of profits of associates
----
----
-33.58%109.56M
----
----
----
-0.04%164.94M
----
--90.2M
----
Share of profit from joint venture company
----
----
-396.41%-12.17M
----
----
----
8.72%-2.45M
----
---3.99M
----
Special items of earning before tax
----
-45.34%1.19M
----
123.46%1.99M
----
52.47%2.17M
----
0.84%-8.49M
----
--1.42M
Earning before tax
-8.47%4.53B
-7.81%2.91B
13.62%8.75B
-1.34%6.57B
-7.12%4.95B
-9.93%3.16B
-48.25%7.7B
-50.36%6.66B
5.33B
-21.88%3.5B
Tax
----
31.26%-474.32M
1.92%-1.4B
-0.77%-1.15B
----
-17.52%-690.06M
41.44%-1.43B
49.48%-1.14B
---782.48M
44.46%-587.18M
After-tax profit from continuing operations
-1.25%2.44B
17.16%7.35B
-1.78%5.42B
-15.45%2.47B
-49.59%6.27B
-50.53%5.52B
4.55B
-14.91%2.92B
Earning after tax
-1.25%2.44B
17.16%7.35B
-1.78%5.42B
-15.45%2.47B
-49.59%6.27B
-50.53%5.52B
4.55B
-14.91%2.92B
Minority profit
----
-22.06%128.75M
-51.82%557.91M
-75.71%216.93M
----
-53.22%165.2M
-57.35%1.16B
-66.58%893.09M
--579.46M
-36.74%353.15M
Profit attributable to shareholders
-14.94%3.29B
0.25%2.31B
32.77%6.79B
12.49%5.21B
-2.69%3.87B
-10.25%2.3B
-47.42%5.11B
-45.48%4.63B
3.97B
-10.66%2.56B
Basic earnings per share
-14.94%1.5893
-15.09%1.1148
27.72%3.282
6.79%2.5165
-8.16%1.8685
0.00%1.3129
-48.42%2.5697
-45.80%2.3566
2.0345
-10.66%1.3129
Diluted earnings per share
-15.09%1.1148
27.72%3.282
6.79%2.5165
0.00%1.3129
-48.42%2.5697
-45.80%2.3566
2.0345
-10.66%1.3129
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
IAS
CAS (2007)
CAS (2007)
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
Audit Opinions
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Auditor
--
--
Ernst & Young (Special General Partnership), Ernst & Young
--
--
--
KPMG
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Turnover -----9.45%18.81B24.08%67.54B29.14%50.84B----23.76%20.77B-19.57%54.43B-20.47%39.36B--27.65B-7.45%16.78B
Operating income -12.81%31.26B-9.45%18.81B24.08%67.54B29.14%50.84B29.68%35.86B23.76%20.77B-19.57%54.43B-20.47%39.36B27.65B-7.45%16.78B
Cost of sales ---------17.98%-46.69B------------12.80%-39.57B-------18.43B----
Operating expenses 14.94%-12.54B-17.98%-46.69B-28.15%-34.7B-33.14%-14.75B12.80%-39.57B14.08%-27.08B-18.43B-0.87%-11.08B
Gross profit 4.00%6.26B40.33%20.85B31.33%16.14B5.56%6.02B-33.34%14.86B-31.68%12.29B9.22B-20.22%5.71B
Selling expenses -----17.90%-2.41B-117.13%-10.74B-162.28%-6.94B-----40.14%-2.05B8.52%-4.95B-28.36%-2.65B---2.46B34.55%-1.46B
Administrative expenses -----6.54%-475.64M-1.10%-2.6B-15.74%-1.54B-----3.58%-446.46M5.16%-2.57B-4.08%-1.33B---1.07B18.88%-431.04M
Research and development expenses ----49.22%-355K-49.69%-58.42M---9.78M-------699.06K---39.03M------------
Profit from asset sales -----673.05%-1.52M-----53.02%1.09M-----123.95%-196.59K----286.02%2.31M------820.78K
Impairment and provision -----5.16%-147.19M-64.00%2.58M-44.35%-473.95M-----407.71%-139.97M130.70%7.16M-110.31%-328.34M--7.58M1,811.40%45.49M
-Other impairment is provision -----5.16%-147.19M-64.00%2.58M-44.35%-473.95M-----407.71%-139.97M130.70%7.16M-110.31%-328.34M--7.58M1,811.40%45.49M
Special items of operating profit ----29.38%22.76M255.24%1.49B-72.08%68.58M-----65.32%17.59M-46.58%420.08M-25.37%245.63M---334.17M-64.76%50.73M
Operating profit -8.47%4.53B-2.12%2.78B15.75%8.95B-17.91%5.99B-7.59%4.95B-16.92%2.84B-48.25%7.73B-45.90%7.3B5.36B-24.44%3.42B
Financing cost -----59.74%124.94M-53.41%-297.89M193.04%581.83M----289.80%310.32M12.48%-194.18M-991.32%-625.37M---111.07M251.89%79.61M
Share of profits of associates ---------33.58%109.56M-------------0.04%164.94M------90.2M----
Share of profit from joint venture company ---------396.41%-12.17M------------8.72%-2.45M-------3.99M----
Special items of earning before tax -----45.34%1.19M----123.46%1.99M----52.47%2.17M----0.84%-8.49M------1.42M
Earning before tax -8.47%4.53B-7.81%2.91B13.62%8.75B-1.34%6.57B-7.12%4.95B-9.93%3.16B-48.25%7.7B-50.36%6.66B5.33B-21.88%3.5B
Tax ----31.26%-474.32M1.92%-1.4B-0.77%-1.15B-----17.52%-690.06M41.44%-1.43B49.48%-1.14B---782.48M44.46%-587.18M
After-tax profit from continuing operations -1.25%2.44B17.16%7.35B-1.78%5.42B-15.45%2.47B-49.59%6.27B-50.53%5.52B4.55B-14.91%2.92B
Earning after tax -1.25%2.44B17.16%7.35B-1.78%5.42B-15.45%2.47B-49.59%6.27B-50.53%5.52B4.55B-14.91%2.92B
Minority profit -----22.06%128.75M-51.82%557.91M-75.71%216.93M-----53.22%165.2M-57.35%1.16B-66.58%893.09M--579.46M-36.74%353.15M
Profit attributable to shareholders -14.94%3.29B0.25%2.31B32.77%6.79B12.49%5.21B-2.69%3.87B-10.25%2.3B-47.42%5.11B-45.48%4.63B3.97B-10.66%2.56B
Basic earnings per share -14.94%1.5893-15.09%1.114827.72%3.2826.79%2.5165-8.16%1.86850.00%1.3129-48.42%2.5697-45.80%2.35662.0345-10.66%1.3129
Diluted earnings per share -15.09%1.114827.72%3.2826.79%2.51650.00%1.3129-48.42%2.5697-45.80%2.35662.0345-10.66%1.3129
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)IASCAS (2007)CAS (2007)CAS (2007)IASCAS (2007)IASCAS (2007)
Audit Opinions ----Unqualified Opinion------Unqualified Opinion------
Auditor ----Ernst & Young (Special General Partnership), Ernst & Young------KPMG------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg